Revvity (RVTY) Cash from Investing Activities (2009 - 2026)
Revvity's (RVTY) quarterly Cash from Investing Activities came in at -$3.5 million in Q3 2026, up 81.42% on a YoY basis from -$1.9 million in Q3 2025, and up 95.52% quarter-over-quarter from -$78.3 million in Q2 2026.
Analysis
Revvity (RVTY) Cash from Investing Activities (2009 - 2026) Analysis & Trends
Revvity (RVTY) has reported Cash from Investing Activities for 18 consecutive years, with -$3.5 million the latest figure, recorded in Q3 2026.
- For the quarter ending Q3 2026, Cash from Investing Activities rose 81.42% year-over-year to -$3.5 million; the trailing twelve-month figure through Jul 2026 stood at -$120.8 million (down 118.92% YoY), and the FY2025 full-year result was -$73.6 million, down 109.48% from the prior year.
- Cash from Investing Activities advanced to -$3.5 million in Q3 2026 per RVTY's latest filing, from -$78.3 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $3.9 billion in Q1 2023 and bottomed at -$571.0 million in Q3 2023.
- Historically, Cash from Investing Activities has averaged $362.4 million across 5 years, with a median of -$17.8 million in 2024.
- The sharpest annual moves came in 2023 and 2026: Cash from Investing Activities surged 3411.37% in 2023, then slumped 396.87% in 2026.
- Over 5 years, Cash from Investing Activities stood at -$56.3 million in 2022, then tumbled by 636.7% to -$414.8 million in 2023, then surged by 95.82% to -$17.3 million in 2024, then dropped by 18.02% to -$20.5 million in 2025, then surged by 82.86% to -$3.5 million in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$3.5 million, -$78.3 million, and -$20.5 million for Q3 2026, Q2 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 164.00 Mn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | -10.15 Bn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | -1.03 Bn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | -122.00 Mn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | -3.51 Mn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | -7.06 Mn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | -66.70 Mn |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | -2.09 Mn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | -7.74 Mn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | -25.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 5, 2026 | -3.51 Mn |
| Apr 5, 2026 | -78.27 Mn |
| Dec 28, 2025 | -20.45 Mn |
| Sep 28, 2025 | -18.53 Mn |
| Jun 29, 2025 | -18.87 Mn |
| Mar 30, 2025 | -15.75 Mn |
| Dec 29, 2024 | -17.33 Mn |
| Sep 29, 2024 | 690.18 Mn |
| Jun 30, 2024 | 121.49 Mn |
| Mar 31, 2024 | -18.18 Mn |
| Dec 31, 2023 | -414.81 Mn |
| Oct 1, 2023 | 434.87 Mn |
| Jul 2, 2023 | -571.04 Mn |
| Apr 2, 2023 | 1.86 Bn |
| Jan 1, 2023 | 3.92 Bn |
| Apr 3, 2022 | -56.31 Mn |
| Oct 3, 2021 | -3.30 Bn |
| Jul 4, 2021 | -290.03 Mn |
| Apr 4, 2021 | -461.85 Mn |
| Jan 3, 2021 | -436.40 Mn |